Udaipur, 24 August (Kiran News): The three-day international conference “Trends of Transformation in Oncology” concluded in Lake City Udaipur, emphasising the importance of adopting both new and traditional cancer treatments as per patients’ needs. Over 100 cancer specialists from India and abroad participated, sharing their clinical experiences and insights on evolving therapies.
Focus on Advanced Therapies and Research
Conference Chairman Dr. Manoj Mahajan shared that the final day featured a session on gastroesophageal cancer, where experts discussed the latest advancements in CAR T and TCR therapies based on targeted antigens like CLDN 18.2 and HER2. The role of ctDNA in cancer detection, tracking disease progression, and monitoring treatment response was particularly highlighted, with experts noting its increasing significance in clinical practice. The session concluded with case discussions on advanced cancer, offering practical perspectives for attending doctors.
Dr. Saurabh Sharma informed that another technical session focused on gynecological cancers such as ovarian and cervical cancer. Detailed discussions covered the potential of CAR T, TCR, and TIL therapies, along with strategies for early detection, monitoring recurrence, and initiating timely treatment. Panel discussions provided clinicians with a comprehensive approach to patient care.
Comprehensive Sessions on Modern Oncology
Dr. Mahajan, in his closing remarks, summarised the three days of discussions, research, and achievements, expressing gratitude to the participants for their contributions. He highlighted that the conference covered in-depth topics such as cellular therapy, liquid biopsy, and immunotherapy. On the first day, experts discussed the current landscape of CAR T therapy, its approved applications, biomarker-based patient selection, and side effects such as CRS and ICANS. Emerging frontiers in the field, including dual-target CARs and gene-edited cells, were also explored.
The second day saw sessions on the role of cellular therapy in breast, lung, head and neck, renal, and prostate cancers. Participants learned about techniques for monitoring disease progression and treatment response using ctDNA and CTCs. A special workshop was also organised on setting up CAR T-cell units.
On the third day, sessions focusing on gastroesophageal and gynecological cancers gave the conference a comprehensive outlook. The conference successfully connected doctors with the latest research, new technologies, and practical experiences, offering clear direction for the future of cancer care.
Bhupendra Singh Chundawat is a seasoned technology journalist with over 22 years of experience in the media industry. He specializes in covering the global technology landscape, with a deep focus on manufacturing trends and the geopolitical impact on tech companies. Currently serving as the Editor at Udaipur Kiran, his insights are shaped by decades of hands-on reporting and editorial leadership in the fast-evolving world of technology.
